On July 20, 2026, Oncolytics Biotech Inc. (ONCY) was notified by Nasdaq of its failure to maintain the required minimum bid price of $1.00 for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The company has until January 19, 2027, to regain compliance, with the possibility of a 180-day extension if certain conditions are met. Trading under the symbol ONCY continues on the Nasdaq Capital Market.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.tradingview.com/news/tradingview:9cbbbf3300d92:0-oncolytics-biotech-disclosed-failure-to-satisfy-a-continued-listing-rule-or-standard/
